Hanall Biopharma Co., Ltd. 009420.KS Stock
Hanall Biopharma Co., Ltd. Price Chart
Hanall Biopharma Co., Ltd. 009420.KS Financial and Trading Overview
| Hanall Biopharma Co., Ltd. stock price | 32800 KRW |
| Previous Close | 21350 KRW |
| Open | 21500 KRW |
| Bid | 21650 KRW x 0 |
| Ask | 21700 KRW x 0 |
| Day's Range | 21400 - 22400 KRW |
| 52 Week Range | 12450 - 24500 KRW |
| Volume | 431.96K KRW |
| Avg. Volume | 484.81K KRW |
| Market Cap | 1.1T KRW |
| Beta (5Y Monthly) | 0.774657 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30167 KRW |
009420.KS Valuation Measures
| Enterprise Value | 1.02T KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.60327 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 8.919 |
| Enterprise Value/EBITDA | 288.549 |
Trading Information
Hanall Biopharma Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.774657 |
| 52-Week Change | 35.55% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 24500 KRW |
| 52 Week Low | 12450 KRW |
| 50-Day Moving Average | 21713.6 KRW |
| 200-Day Moving Average | 17198.95 KRW |
009420.KS Share Statistics
| Avg. Volume (3 month) | 484.81K KRW |
| Avg. Daily Volume (10-Days) | 396.29K KRW |
| Shares Outstanding | 50.69M |
| Float | 34.5M |
| Short Ratio | N/A |
| % Held by Insiders | 30.99% |
| % Held by Institutions | 14.32% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -0.80% |
| Operating Margin (ttm) | 0.31% |
| Gross Margin | 56.45% |
| EBITDA Margin | 3.09% |
Management Effectiveness
| Return on Assets (ttm) | 0.11% |
| Return on Equity (ttm) | -0.57% |
Income Statement
| Revenue (ttm) | 114.81B KRW |
| Revenue Per Share (ttm) | 2264.8 KRW |
| Quarterly Revenue Growth (yoy) | 20.10% |
| Gross Profit (ttm) | 61.88B KRW |
| EBITDA | 3.55B KRW |
| Net Income Avi to Common (ttm) | -919308672 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 59.57B KRW |
| Total Cash Per Share (mrq) | 1175.13 KRW |
| Total Debt (mrq) | 1.29B KRW |
| Total Debt/Equity (mrq) | 0.78 KRW |
| Current Ratio (mrq) | 3.722 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 18.02B KRW |
| Levered Free Cash Flow (ttm) | -9588201472 KRW |
Profile of Hanall Biopharma Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | Daewoong Building |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.hanall.co.kr |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.
Q&A For Hanall Biopharma Co., Ltd. Stock
What is a current 009420.KS stock price?
Hanall Biopharma Co., Ltd. 009420.KS stock price today per share is 32800 KRW.
How to purchase Hanall Biopharma Co., Ltd. stock?
You can buy 009420.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hanall Biopharma Co., Ltd.?
The stock symbol or ticker of Hanall Biopharma Co., Ltd. is 009420.KS.
Which industry does the Hanall Biopharma Co., Ltd. company belong to?
The Hanall Biopharma Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hanall Biopharma Co., Ltd. have in circulation?
The max supply of Hanall Biopharma Co., Ltd. shares is 50.7M.
What is Hanall Biopharma Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hanall Biopharma Co., Ltd. PE Ratio is now.
What was Hanall Biopharma Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hanall Biopharma Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Hanall Biopharma Co., Ltd. company belong to?
The Hanall Biopharma Co., Ltd. sector is Healthcare.